HUM vs IMDX · P/E 39, rev $117.76B vs rev $1.9M
Humana Inc (HUM) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IMDX revenue for 2024-12-31 was $1.9M. Net income was -$60.7M. Revenue was up 25.1% from 2023-12-31 to 2024-12-31. IMDX currently screens at market cap $0.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IMDX currently screens at market cap $0.
Not investment advice. Open the HUM and IMDX stock pages for the full models.
Not investment advice.